Entertainment Women's alert cry with breast cancer Faced with the shortage of a drug
COVID-19: India promises 120 million vaccine doses for June
This marks a significant jump from the 79 million doses available in May as government tries to plug the jab shortage.This marks a significant jump from the 79.4 million doses that were available in May amid the devastating second wave that has killed more than 150,000 people in the past eight weeks.
Theis the most severe form of the disease. But a medicine can lengthen a few months - or even doubling - the life expectancy of the patients: the Todelvy.
"According to official figures, the survival median is 14 months," explains toClaude broker, achieving this cancer and founder of the collective #MobilizationTriplets. "Fourteen months, it's short. So, this medicine, it allows to double the life expectancy," she ensures. Only
, a major problem stands between French patients (they are about 600 to be involved,) and treatment. Beyond the fact that it is still pending European authorizations, it is only achieved by the American Gilead laboratory, holder of the patent, which declares that they do not have sufficient production capacity to provide Europe.
Why a Labor Shortage Would Be a Good Thing
Workers should have the power to say no to employers.The familiar story about what’s happening goes like this: America is in the midst of a labor shortage. Businesses are unable to find enough workers, in no small part because of the country’s generous unemployment-insurance payments and repeated stimulus checks. This is a nightmare for growing companies, a trend that’s slowing the economic recovery, and a problem that policy must solve. Workers are “dampening what should be a stronger jobs market,” the Chamber of Commerce said, calling the situation a “very real threat” to the recovery.
The French headquarters of the company, however, advances a solution: by exclusive to those who need it most."And the others, we let them die?"
"We are under construction of this capacity for Europe and for other countries elsewhere, outside the United States," details in FranceEinfo Michel Joly, President of Gilead France. For the manager, we still have to wait a few months in order to have access to this side of the Atlantic. "We will have a medicine that will be available at the time of the European marketing authorization, that is, at the end of the year."
A delay of concern for women who, precisely, do not possess this precious time. What Michel Joly answers: "But in the meantime, of course, aware of the situation of these patients, we were able to take a few thousand bottles on American production to give access to Trodelvy a few dozen patients who are in a situation. 'emergency." 78, exactly, selected on criteria that remain fuzzy until a factory is built in Italy, specifies the media.
The cancer patients being treated in their homes due to COVID
Doctors in Italy fear another health emergency may soon arise – of non-COVID patients neglected during the pandemic.Ermelinda has been self-isolating for nearly two months after she – and then her husband – caught the coronavirus. The hope is that today her PCR test will show a negative result and that she will be able to resume her chemotherapy, for the breast cancer she has been battling on and off for 30 years. It is recommended that cancer patients with COVID suspend their chemotherapy treatment as it can increase the risk of severe complications from the virus.
For Claude broker, it's far from sufficient. Because she is hammering: no question of sorting. All patients should be able to benefit from this chance to see their days multiply. "78 women, it's great, but, and the others, let them die? What do we do?" She is indignant. "End of December, part of these 600 women will be died. We can not wait."
and adding, insisting on a unknown fact by people who do not face it: "What must be understood too, it is that this triple negative breast cancer. Young moms, even . It is absolutely necessary solutions, we can not accept that, we can not stay without doing anything, it is not possible. "
with #MobilizationTriplets, it decided to exclude anyone, and ask Gilead an "additional gesture": that the treatment is lavish to the 600 French patients for the next few months.
Family slams daughter's 'substandard' cancer treatment at Adelaide Women's and Children's Hospital .
Mabelle Kayser has undergone treatment at Adelaide's Women's and Children's Hospital after being diagnosed with a rare cancer, but her parents say she has been left "screaming out in pain" at times.The 14-year-old was diagnosed in January, after finding a lump on her side, and has undergone major surgery to remove a rib.